Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and lysine

sorafenib has been researched along with lysine in 4 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(lysine)		Trials
(lysine)		Recent Studies (post-2010) (lysine)
6,5207305,25137,44962211,213

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)lysine (IC50)
Cationic amino acid transporter 3Homo sapiens (human)158

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Bock, T; Buechel, D; Christofori, G; Dazert, E; Gao, R; Hall, MN; Heim, MH; Hergovich, A; Hindupur, SK; Jeevan-Raj, B; Kalathur, RKR; Lim, DS; Matthias, P; Morini, MF; Ng, CKY; Nuciforo, S; Piscuoglio, S; Song, S; Tang, F; Terracciano, LM; Wyss, CB1
Chen, XF; Ji, S1
Liu, J; Nie, C1
Li, N; Lv, S; Ma, X; Song, T; Sun, L; Yan, Y; Zhang, E; Zhao, X; Zou, Q1

Other Studies

4 other study(ies) available for sorafenib and lysine

ArticleYear
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.
    Nature communications, 2019, 12-17, Volume: 10, Issue:1

    Topics: Animals; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Datasets as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Hippo Signaling Pathway; Humans; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Lysine; Mice; Mice, Knockout; Organoids; Protein Serine-Threonine Kinases; Protein Stability; Signal Transduction; Sorafenib; Tumor Suppressor Proteins; Ubiquitination; Xenograft Model Antitumor Assays

2019
Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation.
    Drug design, development and therapy, 2022, Volume: 16

    Topics: Animals; Carbon Tetrachloride; Liver; Liver Cirrhosis; Lysine; Male; Rats; Rats, Sprague-Dawley; Sorafenib

2022
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma.
    Anti-cancer drugs, 2022, 10-01, Volume: 33, Issue:9

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Jumonji Domain-Containing Histone Demethylases; Liver Neoplasms; Lysine; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Repressor Proteins; Sorafenib; Tensins

2022
Lysine demethylase KDM1A promotes cell growth via FKBP8-BCL2 axis in hepatocellular carcinoma.
    The Journal of biological chemistry, 2022, Volume: 298, Issue:9

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Histone Demethylases; Histones; Humans; Liver Neoplasms; Lysine; Proto-Oncogene Proteins c-bcl-2; Sorafenib; Tacrolimus Binding Proteins

2022